Maggie Shepherd

7.5k total citations · 1 hit paper
92 papers, 5.1k citations indexed

About

Maggie Shepherd is a scholar working on Surgery, Genetics and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Maggie Shepherd has authored 92 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Surgery, 49 papers in Genetics and 43 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Maggie Shepherd's work include Pancreatic function and diabetes (67 papers), Diabetes and associated disorders (39 papers) and Diabetes Management and Research (36 papers). Maggie Shepherd is often cited by papers focused on Pancreatic function and diabetes (67 papers), Diabetes and associated disorders (39 papers) and Diabetes Management and Research (36 papers). Maggie Shepherd collaborates with scholars based in United Kingdom, Sweden and United States. Maggie Shepherd's co-authors include Andrew T. Hattersley, Sian Ellard, Beverley M. Shields, Kevin Colclough, Ewan R. Pearson, Sarah E. Flanagan, Sarah Hicks, Timothy J. McDonald, Charlotte E. Rees and Timothy M. Frayling and has published in prestigious journals such as Journal of Clinical Investigation, Nature Medicine and Nature Communications.

In The Last Decade

Maggie Shepherd

88 papers receiving 4.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Maturity-onset diabetes of the young (MODY): how many cases are we missing?

2010 493 citations Beverley M. Shields, Maggie Shepherd et al. Diabetologia profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Maggie Shepherd United Kingdom	36	3.9k	3.4k	2.2k	1.7k	267	92	5.1k
David Thompson Canada	25	1.5k 0.4×	611 0.2×	860 0.4×	483 0.3×	171 0.6×	63	2.6k
Patricia P. Moll United States	27	552 0.1×	679 0.2×	733 0.3×	534 0.3×	288 1.1×	51	3.3k
Ahmad Shabsigh United States	31	1.7k 0.4×	180 0.1×	653 0.3×	742 0.4×	128 0.5×	84	3.7k
Megan R. Haymart United States	33	1.7k 0.4×	610 0.2×	3.1k 1.4×	509 0.3×	88 0.3×	118	4.3k
Leslie J. Raffel United States	23	486 0.1×	938 0.3×	528 0.2×	318 0.2×	179 0.7×	55	1.7k
Laure El ghormli United States	23	444 0.1×	585 0.2×	509 0.2×	682 0.4×	209 0.8×	58	2.7k
Donald S.A. McLeod Australia	25	476 0.1×	337 0.1×	1.4k 0.6×	417 0.2×	80 0.3×	87	2.9k
Marian J.E. Mourits Netherlands	38	671 0.2×	1.6k 0.5×	246 0.1×	456 0.3×	166 0.6×	139	4.6k
Martin Lange Spain	23	499 0.1×	233 0.1×	1.4k 0.7×	302 0.2×	152 0.6×	75	2.0k
Geneviève Plu‐Bureau France	34	199 0.1×	1.3k 0.4×	1.7k 0.8×	340 0.2×	356 1.3×	120	3.9k

Countries citing papers authored by Maggie Shepherd

Since Specialization

Citations

This map shows the geographic impact of Maggie Shepherd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maggie Shepherd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maggie Shepherd more than expected).

Fields of papers citing papers by Maggie Shepherd

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maggie Shepherd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maggie Shepherd. The network helps show where Maggie Shepherd may publish in the future.

Co-authorship network of co-authors of Maggie Shepherd

This figure shows the co-authorship network connecting the top 25 collaborators of Maggie Shepherd. A scholar is included among the top collaborators of Maggie Shepherd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maggie Shepherd. Maggie Shepherd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hughes, Alice E., Jayne Houghton, Ali Chakera, et al.. (2023). Bringing precision medicine to the management of pregnancy in women with glucokinase-MODY: a study of diagnostic accuracy and feasibility of non-invasive prenatal testing. Diabetologia. 66(11). 1997–2006. 4 indexed citations

Sugg, Holly Victoria Rose, David Richards, Anne‐Marie Russell, et al.. (2022). Nurses’ strategies for overcoming barriers to fundamental nursing care in patients with COVID ‐19 caused by infection with the SARS‐COV ‐2 virus: Results from the ‘ COVID‐NURSE ’ survey. Journal of Advanced Nursing. 79(3). 1003–1017. 7 indexed citations

Shields, Beverley M., Maggie Shepherd, Nicky Britten, et al.. (2022). Patient preference for second- and third-line therapies in type 2 diabetes: a prespecified secondary endpoint of the TriMaster study. Nature Medicine. 29(2). 384–391. 8 indexed citations

Colclough, Kevin, Maggie Shepherd, Joanne McLean, et al.. (2022). Improvements in Awareness and Testing Have Led to a Threefold Increase Over 10 Years in the Identification of Monogenic Diabetes in the U.K.. Diabetes Care. 45(3). 642–649. 25 indexed citations

Whear, Rebecca, Rebecca Abbott, Alison Bethel, et al.. (2021). Impact of COVID‐19 and other infectious conditions requiring isolation on the provision of and adaptations to fundamental nursing care in hospital in terms of overall patient experience, care quality, functional ability, and treatment outcomes: systematic review. Journal of Advanced Nursing. 78(1). 78–108. 15 indexed citations

Carlsson, Annelie, Maggie Shepherd, Sian Ellard, et al.. (2019). Absence of Islet Autoantibodies and Modestly Raised Glucose Values at Diabetes Diagnosis Should Lead to Testing for MODY: Lessons From a 5-Year Pediatric Swedish National Cohort Study. Diabetes Care. 43(1). 82–89. 73 indexed citations

Bowman, Pamela, Timothy J. McDonald, Bridget Knight, et al.. (2019). Patterns of postmeal insulin secretion in individuals with sulfonylurea-treated KCNJ11 neonatal diabetes show predominance of non-K_ATP-channel pathways. BMJ Open Diabetes Research & Care. 7(1). e000721–e000721. 8 indexed citations

Shepherd, Maggie, et al.. (2018). Exploring NursEs lived Experience of Discussions about Sexual health, with kidney patients in Devon (NEEDS). Nursing Open. 5(3). 442–449. 5 indexed citations

Bowman, Pamela, Jacob Day, Lorna Torrens, et al.. (2018). Cognitive, Neurological, and Behavioral Features in Adults With KCNJ11 Neonatal Diabetes. Diabetes Care. 42(2). 215–224. 21 indexed citations

10.

Patel, Kashyap, Jarno L. T. Kettunen, Markku Laakso, et al.. (2017). Heterozygous RFX6 protein truncating variants are associated with MODY with reduced penetrance. Nature Communications. 8(1). 888–888. 87 indexed citations

11.

Shields, Beverley M., Maggie Shepherd, Michelle Hudson, et al.. (2017). Population-Based Assessment of a Biomarker-Based Screening Pathway to Aid Diagnosis of Monogenic Diabetes in Young-Onset Patients. Diabetes Care. 40(8). 1017–1025. 97 indexed citations

12.

Edghill, Emma L., Karen Stals, Richard A. Oram, et al.. (2012). HNF1B deletions in patients with young‐onset diabetes but no known renal disease. Diabetic Medicine. 30(1). 114–117. 32 indexed citations

13.

Shepherd, Maggie. (2009). Genetic testing clarifies diagnosis and treatment in a family with both HNF1A and type 1 diabetes. Practical Diabetes International. 26(7). 269–269.

14.

Spyer, Gill, K. M. MacLeod, Maggie Shepherd, Sian Ellard, & Andrew T. Hattersley. (2008). Pregnancy outcome in patients with raised blood glucose due to a heterozygous glucokinase gene mutation. Diabetic Medicine. 26(1). 14–18. 89 indexed citations

15.

John, H T, et al.. (2005). Neonatal diabetes is more than just a paediatric problem: 57 years of diabetes from a Kir6.2 mutation. Practical Diabetes International. 22(9). 342–344. 2 indexed citations

16.

Shepherd, Maggie. (2003). Genetic testing in maturity onset diabetes of the young (MODY) – practical guidelines for professionals. Practical Diabetes International. 20(3). 108–110. 5 indexed citations

17.

Bulman, M., Lorna W. Harries, Torben Hansen, et al.. (2002). Abnormal splicing of hepatocyte nuclear factor 1 alpha in maturity-onset diabetes of the young. Diabetologia. 45(10). 1463–1467. 21 indexed citations

18.

Frayling, Timothy M., Julie Evans, M. Bulman, et al.. (2001). beta-cell genes and diabetes: molecular and clinical characterization of mutations in transcription factors.. Diabetes. 50(suppl_1). S94–S94. 202 indexed citations

19.

Shepherd, Maggie, Ian O. Ellis, P. Todd, et al.. (2001). Predictive genetic testing in maturity‐onset diabetes of the young (MODY). Diabetic Medicine. 18(5). 417–421. 60 indexed citations

20.

Shepherd, Maggie. (1995). User involvement. Self-service.. PubMed. 105(5450). 24–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact